N521-19B_21 Advanced Pharmacology Assignment 3

N521-19B_21 Advanced Pharmacology Assignment 3

N521-19B_21 Advanced Pharmacology Assignment 3

Permalink: https://ulcius.com/n521-19b_21-adva…ogy-assignment-3/

Assignment 3

L. P., age 23, is a Hispanic woman who graduated from college last year. She reports to the CNP in her local community mental health center. She began working as an accountant 1 month after graduating. Approximately 2 months ago, she moved into a two-bedroom apartment with another woman who works at the same accounting firm. She states that her roommate recommended that she see a doctor to find out if she has anemia or “some sort of fatigue syndrome.” She states that she has felt “restless” and “on edge” for most of the past 9 months. She becomes easily fatigued and irritable and has difficulty concentrating and falling asleep. She states that sometimes her mind “just goes blank,” and she is worried that her work performance is no longer excellent. She reports that all her life she had good grades in school and was very successful in everything she attempted. Although she has been “a worrier from the day I was born,” now she worries more than she ever has and feels nervous “all the time.” L. P. reports that she has a good relationship with her boyfriend but they do not get to see each other very often because he is attending graduate school 100 miles away. She reports having a satisfying sexual relationship with him. She denies having any problems with relationships with her parents, roommate, or peers. She denies having any financial worries unless she is fired from her job for poor work performance. She reports that she has always been healthy and has taken good care of herself. The only medication she takes is birth control pills, which she has taken for the past 4 years without any adverse effects. N521-19B_21 Advanced Pharmacology Assignment 3

In a paper not to exceed six pages, excluding title and reference pages, submit your answers to the following in an MS Word document:

  1. What is L. P.’s likely diagnosis?
  2. List specific pharmacotherapeutic treatment goals for L. P.
  3. Should the CNP order any labs for L. P. at this time? Why?
  4. What drug therapy would the CNP likely prescribe? Why?
  5. What are the parameters for monitoring the success of the therapy?
  6. Describe specific patient monitoring based on the prescribed therapy.
  7. List one or two adverse reactions for the selected agent that would cause the CNP to change therapy.
  8. L. P. returns to see the CNP after six weeks, complaining of still feeling anxious and had heard of a medication called Klonopin that she would like to try; how should the CNP respond to her request?
  9. What health promotion activities should be recommended for this patient?
  10. What is L. P.’s long-term prognosis?

Please use the Case Study Analysis rubric provided to guide you in completing this assignment. It will be used to evaluate your submitted work.

Competency

40

36

33

0

Points Earned

Case Study questions completely and thoroughly answered with accurate evidence-based supported rationales N521-19B_21 Advanced Pharmacology Assignment 3 Accurate and well defined discussion of all 10 questions for the case study using current evidence-based resources. Accurate discussion of nine case study questions  presented with use of  current evidence-based resources. Accurate discussion of 8 questions using current evidence-based resources

Missing response to questions or inappropriate answers to questions. No use of evidence-based resources.

/40

40

36

33

0

Evidence of

  • critical thinking
  • therapeutic decision-making in drug selection and evaluation of patient care
  • pathophysiology and current pharmacological research
  • assessment of the effectiveness of drug therapy
  • formulation of clinical care and teaching plans for persons from diverse populations
Well-defined evidence of

  • critical thinking
  • therapeutic decision-making in drug selection and evaluation of patient care
  • pathophysiology and current pharmacological research
  • assessment of the effectiveness of drug therapy
  • formulation of clinical care and teaching plans for persons from diverse populations
Evidence of critical thinking in prescriptive therapy, monitoring and adverse events.  May have lacked a teaching plan or pathophysiologic discussion. Evidence of critical thinking but incompletely described therapeutic decision making and omitted teaching plan and pathophysiology.

Multiple bulleted points are absent or poorly defined in the assignment. There is no demonstration of critical thinking.

/40

Competency

10

9

8

0

Points Earned

Grammar, spelling, and punctuation There are no errors in grammar, spelling, and punctuation There are a few minor errors in grammar, spelling, and punctuation that do not detract from the meaning (1-3 errors) There are major errors in grammar, spelling, and punctuation .(4-5 errors) N521-19B_21 Advanced Pharmacology Assignment 3 No content or more than 5 errors

/10

Competency

10

9

8

0

APA Compliance

The paper meets APA formatting guidelines

There are a few minor errors (1-3 errors)

There are significant errors in the format of the paper (4-5 errors)

No content or more than 5 errors

/10

Total Points

/100

Competency

 

40

 

36

 

33

 

0

 

Points Earned

 

Case Study questions completely and thoroughly answered with accurate evidence-based supported rationales

 

Accurate and well defined discussion of all 10 questions for the case study using current evidence-based resources.

 

Accurate discussion of nine case study questions  presented with use of  current evidence-based resources.

 

Accurate discussion of 8 questions using current evidence-based resources

 

Missing response to questions or inappropriate answers to questions. No use of evidence-based resources.

 

/40

 

 

 

 

40

 

36

 

33

 

0

 

 

 

 

Evidence of

critical thinking
therapeutic decision-making in drug selection and evaluation of patient care
pathophysiology and current pharmacological research
assessment of the effectiveness of drug therapy
formulation of clinical care and teaching plans for persons from diverse populations. N521-19B_21 Advanced Pharmacology Assignment 3

Well-defined evidence of

critical thinking
therapeutic decision-making in drug selection and evaluation of patient care
pathophysiology and current pharmacological research
assessment of the effectiveness of drug therapy
formulation of clinical care and teaching plans for persons from diverse populations

Evidence of critical thinking in prescriptive therapy, monitoring and adverse events.  May have lacked a teaching plan or pathophysiologic discussion.

 

Evidence of critical thinking but incompletely described therapeutic decision making and omitted teaching plan and pathophysiology.

 

Multiple bulleted points are absent or poorly defined in the assignment. There is no demonstration of critical thinking.

 

/40

 

Competency

 

10

 

9

 

8

 

0

 

Points Earned

 

Grammar, spelling, and punctuation

 

There are no errors in grammar, spelling, and punctuation

 

There are a few minor errors in grammar, spelling, and punctuation that do not detract from the meaning (1-3 errors)

 

There are major errors in grammar, spelling, and punctuation .(4-5 errors)

 

No content or more than 5 errors

 

/10

 

Competency

 

10

 

9

 

8

 

0

 

 

 

 

APA Compliance

 

The paper meets APA formatting guidelines

 

There are a few minor errors (1-3 errors)

 

There are significant errors in the format of the paper (4-5 errors)

 

No content or more than 5 errors

 

/10

 

Total Points

 

 

 

 

 

/100

Discussion 3

M. L. is a 15-year-old Hispanic female who plays soccer for her school team. She has noticed that when running, she sometimes has trouble catching her breath. She also reports an increased runny nose and itchy eyes. She has a frequent dry cough and is awakened with coughing spells at least four times a week. Her mother and father have seasonal allergies and her mother has asthma. This morning she woke up and heard “funny sounds” when she took a breath. Her coughing increased when she took a deep breath. In her nose, the mucosa is pale and swollen bilaterally. Her lungs have bilateral expiratory wheezing; respirations are 22 and PEF is 400. Her heart shows a normal sinus rhythm, with no murmurs or gallops; pulse is 72; and there is no cyanosis. N521-19B_21 Advanced Pharmacology Assignment 3

Diagnosis: Mild Persistent Asthma

In this discussion forum:

  1. Discuss specific goals of pharmacotherapy for treating M. L.’s mild persistent asthma.
  2. Discuss the drug therapy a CNP would likely prescribe and why.
  3. Discuss the parameters for monitoring the success of the therapy.
  4. Discuss age appropriate health promotion recommendations you would consider for M. L.

Remember to respond to at least two of your peers. Please see the Course Syllabus for Discussion Participation Requirements and Grading Criteria.

Example Discussion 3 Approach

Patient M.L. is presenting with mild persistent asthma. This is characterized by having issues with catching her breath while running, having itchy eyes and a runny nose. Also, being woken up by a dry frequent cough a couple times a week. There are specific goals for the pharmacotherapy of treating M.L.’s mild persistent asthma. M.L. will be able to play soccer with more ease and not have as much trouble catching her breath. She will also limit the number of times she is woken up from a dry cough to once a month. Lastly, this patient’s PEF will be >80% of initial reading in three months when the pharmacotherapy is reassessed.

The pharmacotherapy that M.L. would be prescribed is a short acting beta2-adrenergic agonist bronchodilator and a low dose inhaled corticosteroid. A common bronchodilator used is albuterol MDI 90mcg 2 inhalation q6h as needed. This will give the patient quick relief of acute symptoms (Arcangelo, et al. 20017). An example of a corticosteroid would be beclomethasone dipropionate 2 puffs of 40mcg twice a day. “Adherence to daily inhaled corticosteroid therapy is a key determinant of asthma control” (Klok, Kaptein, & Brand, 2015).

The parameters for monitoring the success of therapy depend on multiple things. This patient will need reassessed in 3 months. The CNP will assess if the patient was able to resume normal activities with minimal interruptions including soccer. Also, a decrease in the use of the short-acting bronchodilator. As I stated about if her PEF is >80% from previous her asthma is considered well controlled (Arcangelo, et al. 2017).

Age-appropriate health promotion activities for M.L. would include educating on avoiding environmental triggers. Educating the patient to be aware that there are things in the environment that can trigger her asthma and to notice these and avoid them. Also, education on the importance of taking the medication as prescribed including the daily inhaled corticosteroid. Another important health promotion is to have good nutrition and remain physical active will assist in improving her outcomes with asthma. I would also encourage this patient to create an asthma action plan consisting of goals. This will help motivate the patient to active in their diagnosis and taking the steps to reach these goals.

References

Arcangelo, V.P., Wilbur, V.F., Peterson, A.M., & Reinhold, J.A. (2017). Pharmacotherapeutics for advanced practice: A practical approach, Fourth Edition.  Wolters Kluwer.

Klok, T., Kaptein, A. A., & Brand, P. L. P. (2015). Non-adherence in children with asthma reviewed: The need for improvement of asthma care and medical education. Pediatric Allergy & Immunology26(3), 197–205. https://doi-org.americansentinel.idm.oclc.org/10.1111/pai.12362. N521-19B_21 Advanced Pharmacology Assignment 3